SDRI Earns 4-Star Rating from Charity Navigator and GuideStar Platinum Seal of Transparency
Sansum Diabetes Research Institute (SDRI) has recently been awarded the highest possible ratings from both Charity Navigator and GuideStar, making SDRI one of only 5 non-profit organizations in the area to earn exceptional assessments from both independent charity evaluators. Santa Barbara County has over 2,000 non-profit organizations, this recognition demonstrates to SDRI’s supporters their good governance and financial accountability.
SDRI recently received the 4-star rating from Charity Navigator. Only a quarter of rated charities have achieved this distinction. SDRI was also awarded the 2019 Platinum Seal of Transparency on GuideStar, the world’s largest source of information on nonprofits.
“On behalf of Charity Navigator, I wish to congratulate Sansum Diabetes Research Institute on attaining the coveted 4-star rating for demonstrating strong financial health and commitment to accountability and transparency,” said Michael Thatcher, President and CEO of Charity Navigator. “Attaining a 4-star rating verifies that Sansum Diabetes Research Institute exceeds industry standards and outperforms most charities in their area of work. This exceptional designation from Charity Navigator sets Sansum Diabetes Research Institute apart from its peers and demonstrates to the public its trustworthiness.”
“Sansum Diabetes Research Institute (SDRI) is committed to providing the most ground-breaking programs possible to improve the lives of people with diabetes,” said SDRI Executive Director Ellen Goodstein. “This recognition from GuideStar and Charity Navigator as a top-notch organization–one of only 5 non-profit organizations in Santa Barbara County to earn both–is another reason we have earned a global reputation as a leader in research and innovation, education and care for adults and children living with all forms of diabetes.”
About Sansum Diabetes Research Institute:
Sansum Diabetes Research Institute (SDRI) has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes. With an established world class reputation for innovation in the field of type 1 diabetes including the Artificial Pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to address this growing epidemic. Learn more at www.sansum.org.